Kestra Advisory Services’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Kestra Advisory Services's NVS Position: Q3 2026 in Review
Kestra Advisory Services increased its Novartis (NVS) stake by 4.8% in Q3 2026, buying an estimated $1.37M and bringing the position to 194,907 shares worth $27.8M. The position accounts for 0.08% of the portfolio, ranked #257.
Kestra Advisory Services first reported a position in NVS in Q3 2020 and has held it in 25 quarters since. The position peaked at $29.1M in Q2 2026. 726 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Kestra Advisory Services held 194,907 shares of Novartis worth $27.8M as of Q3 2026.
- Kestra Advisory Services bought 9,001 Novartis shares in Q3 2026, an estimated $1.37M.
- Novartis made up 0.08% of Kestra Advisory Services's portfolio in Q3 2026, its #257 holding.
- Kestra Advisory Services first reported a position in Novartis in Q3 2020 and has held it in 25 quarters since.
- Kestra Advisory Services's Novartis position peaked at $29.1M in Q2 2026.
- 726 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.